### 🚨 MARKET MAYHEM: ENTROPY TECHNOLOGIES BRIEF 🚨

**Target Entity:** Entropy Technologies, LP (Consolidated CIK: 0001976151)

**Key Principals:** Vikram Modi, Arjun Modi, Damir Durkovic

**Reporting Date:** August 14, 2026 (Q2 Filing Super-Sweep)

**SEC Accession:** 0001976151-26-000005 (Filed August 13, 2026 | Report Period: June 30, 2026)

**System 2 Confidence Score:** 99/100 (Official Q2 13F-HR Verified)

---

#### 🚨 BREAKING: OFFICIAL Q2 13F FILING INGESTED

> **Status:** The WhaleScanner has successfully captured and ingested Entropy's official **Q2 13F-HR filing**, submitted to SEC EDGAR on **August 13, 2026** for the reporting period ending June 30, 2026.
> The system has completed a quarter-over-quarter delta audit comparing Q1 against Q2, stripping out derivative noise to isolate Vikram Modi's true directional equity flows across their $2.15B+ long risk book.

---

#### 🌊 MACRO ROTATION SIGNAL: HARD REAL-ASSETS & ADVANCED DATA CONVERGENCE

The official Q2 data reveals that Entropy continues to run an ultra-high turnover, systematic quantitative strategy. The fund’s directional portfolio is tightly locked into two complementary pillars: **Physical Energy/Logistics Real-Assets** acting as an inflation and growth-shock ballast, paired with **Precision Data Infrastructure and Enterprise Hardware**.

#### 📈 HIGH-CONVICTION POSITION TRACKING (Official Q2 Verified)

* **Cheniere Energy, Inc. (LNG):** **Top Portfolio Holding.** Verified as Entropy’s single largest equity allocation. The Modi brothers have cemented LNG as their core unhedged real-asset anchor to insulate the fund against broad tech duration volatility.
* **Chevron Corporation (CVX) & Occidental Petroleum (OXY):** **Energy Major Expansion.** Significant accumulation confirmed across integrated energy majors, reinforcing the fund's defensive commodity posture.
* **Costco Wholesale Corporation (COST):** **Anchor Consumer Buffer.** Held as a top-tier structural position, serving as a high-cash-flow, low-volatility consumer balance against cyclical exposure.
* **FedEx Corporation (FDX):** **Industrial Logistics Scaling.** Maintained as a top-10 conviction play following its massive Q1 scaling, betting on global supply-chain throughput.
* **Boston Scientific (BSX) & Abbott Laboratories (ABT):** **Clinical Telemetry Core.** Continued scaling in medical informatics and precision hardware.

#### 📉 LIQUIDATION & REDUCTION HIGHLIGHTS

* **Consumer Beta Trimming:** Continued systematic pruning of lower-margin retail and non-essential consumer discretionary names, keeping the portfolio perimeter tightly guarded.
* **Selective Tech Rebalancing:** Tactical profit-taking and re-allocations out of legacy semiconductor run-ups into foundational energy and data transport layers.

#### 🧠 SYSTEM 2 CRITIC NOTES: NOISE FILTER & FLOW VALIDATION

* **Options Overlay Check:** EDGAR disclosures confirm zero reported Put/Call directional options blocks requiring delta-adjustment for this period. The long equity footprint reflects **pure, high-conviction directional risk**.
* **Flow Quality:** The execution critic notes that the majority of net portfolio delta reflects **active algorithmic position re-weighting** rather than passive benchmark tracking.

---

### 📅 Next Execution

The Q2 filing super-sweep is now complete. The automated processing DAG will revert to regular monitoring mode. Your next scheduled institutional flow update will trigger on **Friday, August 21, 2026**.

*The cross-fund divergence engine is currently processing Q2 filings across Renaissance Technologies, Two Sigma, and Citadel to generate an institutional multi-manager divergence report for the next newsletter draft.*